ZBiotics
Synthetic biology company that bioengineers probiotic bacteria for nutraceutical and other applications.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
| investor investor | €0.0 | round | |
* | $12.0m | Series A | |
| Total Funding | 000k | ||
Related Content
ZBiotics is a biotechnology company specializing in genetically engineered probiotics designed to break down acetaldehyde, a toxic byproduct of alcohol consumption. The company targets health-conscious consumers who seek to mitigate the negative effects of alcohol. Operating in the health and wellness market, ZBiotics employs a direct-to-consumer business model, selling its products primarily through its website. Revenue is generated through the sale of individual units and subscription plans. The company emphasizes transparency, responsibility, and a people-first approach, with ongoing research aimed at addressing other health challenges such as dairy intolerance, radiation exposure, and lead contamination in water.
Keywords: biotechnology, probiotics, acetaldehyde, alcohol, health, wellness, direct-to-consumer, transparency, research, subscription.